Download PDF
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2013; 10(3): 142-153
DOI: 10.1055/s-0033-1346858
Aktuell diskutiert
Georg Thieme Verlag KG Stuttgart · New York

Brustbildgebung / Mammografie – Bildgebung und Vorgehen bei präinvasiven Läsionen der Mamma

S. Weigel
,
T. Decker
,
W. Heindel
Further Information

Publication History

Publication Date:
12 December 2013 (online)

Also available at
    Permissions and Reprints

Präinvasive Läsionen der Brust umfassen ein Spektrum von biologisch und klinisch heterogenen, neoplastischen Läsionen mit einem sehr unterschiedlichen Progressionspotenzial zum invasiven Brustkrebs. In dieser Übersicht werden Definitionen, diagnostische Kriterien und klinische Schlussfolgerungen zu folgenden Entitäten vorgestellt: duktales Carcinoma in situ (DCIS), atypische duktale Hyperplasie (ADH), flache epitheliale Atypie (FEA), lobuläre Neoplasie (LN).

 

  • Literatur

  • 1 Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003; 5: 313-319
    CrossrefPubMedGoogle Scholar
  • 2 Buerger H, Otterbach F, Simon R et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999; 187: 396-402
    CrossrefPubMedGoogle Scholar
  • 3 Simpson PT, Reis-Filho JS, Gale T et al. Molecular evolution of breast cancer. J Pathol 2005; 205: 248-254
    CrossrefPubMedGoogle Scholar
  • 4 Ellis IO. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod Pathol 2010; 23: S1-S7
    CrossrefPubMedGoogle Scholar
  • 5 Simpson PTP, Gale TB, Reis-Filho JSM et al. Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression? A Morphological and Molecular Analysis. American Journal of Surgical Pathology 2005; 29: 734-746
    CrossrefPubMedGoogle Scholar
  • 6 Buerger H, Schmidt H, Beckmann A et al. Genetic characterisation of invasive breast cancer: a comparison of CGH and PCR based multiplex microsatellite analysis. J Clin Pathol 2001; 54: 836-840
    CrossrefPubMedGoogle Scholar
  • 7 Reis-Filho JS, Simpson PT, Gale T et al. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 2005; 201: 713-725
    PubMedGoogle Scholar
  • 8 American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 2003
    Google Scholar
  • 9 Page DL, Dupont WD, Rogers LW et al. Continued local recurrence of carcinoma 15–25 years after a diagnosis of Low-Grade-ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76: 1197-1200
    CrossrefPubMedGoogle Scholar
  • 10 Wells CA, Amendoeira I, Apostolikas N et al. Quality assurance guidelines for pathology – Cytological and histological non-operative diagnosis. In: Perry NM, Broeders M, de Wolf C, et al., eds European guidelines for quality assurance in breast cancer screening and diagnosis. Luxembourg: Office for Official Publication of the European Communities; 2006
    Google Scholar
  • 11 Weigel S, Girnus R, Czwoydzinski J et al. Digital mammography screening: average glandular dose and first performance parameters. Fortschr Röntgenstr 2007; 179: 892-895
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Hartmann LC, Sellers TA, Frost MH et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353: 229-237
    CrossrefPubMedGoogle Scholar
  • 13 Degnim AC, Visscher DW, Berman HK et al. Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study. J Clin Oncol 2007; 25: 2671-2677
    CrossrefPubMedGoogle Scholar
  • 14 Collins LC, Baer HJ, Tamimi RM et al. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses“ Health Study. Cancer 2007; 109: 180-187
    CrossrefPubMedGoogle Scholar
  • 15 Thomssen C, Harbeck N. Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer – Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer. Breast Care (Basel) 2010; 5: 345-351
    CrossrefPubMedGoogle Scholar
  • 16 Lieske B, Ravichandran D, Alvi A et al. Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur J Surg Oncol 2008; 34: 1293-1298
    CrossrefPubMedGoogle Scholar
  • 17 El-Sayed ME, Rakha EA, Reed J et al. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 2008; 53: 650-657
    CrossrefPubMedGoogle Scholar
  • 18 Weigel S, Decker T, Korsching E et al. Minimal Invasive Biopsy Results of „Uncertain Malignant Potential“ in Digital Mammography Screening: High Prevalence but also High Predictive Value for Malignancy. Fortschr Röntgenstr 2011; 183: 743-748
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Flegg K, Flaherty J, Bicknell A et al. Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program. World Journal of Surgical Oncology 2010; 8: 78
    CrossrefPubMedGoogle Scholar
  • 20 Bijker N, Rutgers EJ, Peterse J L et al. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10 853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 2001; 27: 135-140
    CrossrefPubMedGoogle Scholar
  • 21 de Mascarel I, Macgrogan G, Mathoulin-Pelissier S et al. Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch 2007; 451: 1-10
    PubMedGoogle Scholar
  • 22 Eusebi V, Feudale E, Foschini MP et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223-235
    PubMedGoogle Scholar
  • 23 Badve S, Dabbs DJ, Schnitt SJ et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 2011; 24: 157-167
    CrossrefPubMedGoogle Scholar
  • 24 Abdel-Fatah TMA, Powe DG, Hodi Z et al. Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family. The American Journal of Surgical Pathology 2008; 32: 513-523
    CrossrefPubMedGoogle Scholar
  • 25 Kunju LP, Kleer CG. Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised?. Human Pathology 2007; 38: 35-41
    CrossrefPubMedGoogle Scholar
  • 26 Weigel S, Decker T, Korsching E et al. Calcifications in Digital Mammographic Screening: Improvement of Early Detection of Invasive Breast Cancers?. Radiology 2010; 255: 738-745
    CrossrefPubMedGoogle Scholar
  • 27 Foote FW, Steward FW. Lobular carcinoma in situ. American Journal of Pathology 1941; 17: 491-496
    PubMedGoogle Scholar
  • 28 Haagensen CD, Lane N, Lattes R et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-769
    CrossrefPubMedGoogle Scholar
  • 29 Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC-Press; Classification of Tumours. World Health Organisation 2003
    Google Scholar
  • 30 Lakhani SR, Audretsch W, Cleton-Jensen AM et al. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. European Journal of Cancer 2006; 42: 2205-2211
    CrossrefPubMedGoogle Scholar
  • 31 Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002; 440: 134-138
    CrossrefPubMedGoogle Scholar
  • 32 Hanby AM, Hughes TA. In situ and invasive lobular neoplasia of the breast. Histopathology 2008; 52: 58-66
    PubMedGoogle Scholar
  • 33 Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 2001; 176: 1255-1259
    CrossrefPubMedGoogle Scholar
  • 34 Page DL, Kidd TE, Dupont WD et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232-1239
    CrossrefPubMedGoogle Scholar
  • 35 Akashi-Tanaka S, Fukutomi T, Nanasawa T et al. Treatment of noninvasive carcinoma: fifteen-year results at the National Cancer Center Hospital in Tokyo. Breast Cancer 2000; 7: 341-344
    CrossrefPubMedGoogle Scholar
  • 36 Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 2005; 14: 1008-1011
    CrossrefPubMedGoogle Scholar
  • 37 Frykberg ER. Lobular Carcinoma In Situ of the Breast. Breast J 1999; 5: 296-303
    CrossrefPubMedGoogle Scholar
  • 38 Ottesen GL, Graversen HP, Blichert-Toft M et al. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 1993; 17: 14-21
    CrossrefPubMedGoogle Scholar
  • 39 Ottesen GL, Graversen HP, Blichert-Toft M et al. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197-210
    CrossrefPubMedGoogle Scholar
  • 40 Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 2001; 92: 738-747
    CrossrefPubMedGoogle Scholar
  • 41 Page DL, Schuyler PA, Dupont WD et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125-129
    CrossrefPubMedGoogle Scholar
  • 42 Hussain M, Cunnick GH. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast – a review. European Journal of Surgical Oncology 2011; 37: 279-289
    CrossrefPubMedGoogle Scholar
  • 43 Ciocca RM, Li T, Freedman GM et al. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008; 15: 2263-2271
    CrossrefPubMedGoogle Scholar
  • 44 Deutsche Gesellschaft für Senologie, Deutsche Krebsgesellschaft. Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. München: Zuckschwerdt; 2008
    Google Scholar